| MDN1 |
MDN1, KIAA0301: Midasin |
PTMA |
IPI00015550 |
6.407 |
Evidence |
|
| MDN1 |
MDN1, KIAA0301: Midasin |
NCOA3 |
IPI00220082 |
6.407 |
Evidence |
|
| CSTF2T |
CSTF2T, KIAA0689: Cleavage stimulation factor 64 kDa subunit, tau variant |
IKBKG |
IKBKG, FIP3, NEMO: NF-kappa-B essential modulator |
6.407 |
Evidence |
|
| KIF22 |
KIF22, KID, KNSL4: Kinesin-like protein KIF22 |
TAL1 |
TAL1, SCL, TCL5: T-cell acute lymphocytic leukemia protein 1 |
6.407 |
Evidence |
|
| PPID |
PPID, CYP40, CYPD: 40 kDa peptidyl-prolyl cis-trans isomerase |
LYN |
LYN: Tyrosine-protein kinase Lyn |
6.407 |
Evidence |
|
| SH3BP2 |
SH3BP2: Uncharacterized protein SH3BP2 |
VAV2 |
VAV2, RP11-153P4.1-003: Vav 2 oncogene |
6.407 |
Evidence |
|
| SH3BP2 |
SH3BP2: Uncharacterized protein SH3BP2 |
DEF6 |
DEF6, IBP: Differentially expressed in FDCP 6 |
6.407 |
Evidence |
|
| HIST1H3A |
HIST1H3A, H3FA, HIST1H3B, H3FL, HIST1H3C, H3FC, HIST1H3D, H3FB, HIST1H3E, H3FD, |
LCP2 |
LCP2: Lymphocyte cytosolic protein 2 |
6.407 |
Evidence |
|
| YWHAZ |
YWHAZ: 14-3-3 protein zeta/delta |
MAP4K1 |
MAP4K1, HPK1: Mitogen-activated protein kinase kinase kinase kinase 1 |
6.407 |
Evidence |
|
| YWHAZ |
YWHAZ: 14-3-3 protein zeta/delta |
TRADD |
TRADD: Tumor necrosis factor receptor type 1-associated DEATH domain protein |
6.407 |
Evidence |
|
| SFRS10 |
SFRS10, TRA2B: Splicing factor, arginine/serine-rich 10 |
UBAP2 |
IPI00171127 |
6.407 |
Evidence |
|
| CDKN2D |
CDKN2D: Cyclin-dependent kinase 4 inhibitor D |
SFRS10 |
SFRS10, TRA2B: Splicing factor, arginine/serine-rich 10 |
6.407 |
Evidence |
|
| CDK7 |
CDK7, MO15: Cell division protein kinase 7 |
ESPL1 |
IPI00397474 |
6.407 |
Evidence |
|
| DNM2 |
IPI00218889 |
LYN |
LYN: Tyrosine-protein kinase Lyn |
6.407 |
Evidence |
|
| RGS4 |
RGS4: Regulator of G-protein signaling 4 |
COBL |
IPI00329653 |
6.407 |
Evidence |
|
| SYK |
SYK: Tyrosine-protein kinase SYK |
VAV2 |
VAV2, RP11-153P4.1-003: Vav 2 oncogene |
6.407 |
Evidence |
|
| SYK |
SYK: Tyrosine-protein kinase SYK |
MARK2 |
IPI00718858 |
6.407 |
Evidence |
|
| WAS |
WAS, IMD2: Wiskott-Aldrich syndrome protein |
VAV2 |
VAV2, RP11-153P4.1-003: Vav 2 oncogene |
6.407 |
Evidence |
|
| COIL |
COIL, CLN80: Coilin |
CDK7 |
CDK7, MO15: Cell division protein kinase 7 |
6.407 |
Evidence |
|
| RBMX |
RBMX, HNRPG, RBMXP1: Heterogeneous nuclear ribonucleoprotein G |
TUBA1 |
TUBA4A, TUBA1: Tubulin alpha-4A chain |
6.407 |
Evidence |
|
| ELF1 |
ELF1: ETS-related transcription factor Elf-1 |
PABPC4 |
PABPC4, APP1, PABP4: Polyadenylate-binding protein 4 |
6.407 |
Evidence |
|
| YWHAQ |
YWHAQ: 14-3-3 protein theta |
STUB1 |
STUB1, CHIP, PP1131: STIP1 homology and U box-containing protein 1 |
6.407 |
Evidence |
|
| YWHAQ |
YWHAQ: 14-3-3 protein theta |
ACTR3 |
ACTR3, ARP3: Actin-related protein 3 |
6.407 |
Evidence |
|
| YWHAQ |
YWHAQ: 14-3-3 protein theta |
YWHAB |
YWHAB: 14-3-3 protein beta/alpha |
6.407 |
Evidence |
|
| SAT |
SAT1, SAT: Diamine acetyltransferase 1 |
RGS19 |
RGS19, GAIP, GNAI3IP: Regulator of G-protein signaling 19 |
6.407 |
Evidence |
|